Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

AMERICA HEALTH INC

NPI: 1942836911 · IDAHO FALLS, ID 83404 · Psychologist · NPI assigned 03/20/2020

$1.11M
Total Medicaid Paid
25,441
Total Claims
10,389
Beneficiaries
20
Codes Billed
2021-04
First Month
2024-06
Last Month

Provider Details

Authorized OfficialHATCH, RYAN (CEO)
NPI Enumeration Date03/20/2020

Related Entities

Other providers sharing the same authorized official: HATCH, RYAN

ProviderCityStateTotal Paid
AAA AMERICAN HEALTHCARE LLC IDAHO FALLS ID $8.70M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2021 316 $18K
2022 9,967 $294K
2023 12,520 $621K
2024 2,638 $176K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3,271 2,847 $285K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 3,944 3,609 $236K
H0038 Self-help/peer services, per 15 minutes 1,722 437 $174K
H2017 Psychosocial rehabilitation services, per 15 minutes 1,565 399 $133K
A0100 Non-emergency transportation; taxi 10,952 882 $131K
T1017 Targeted case management, each 15 minutes 1,014 354 $79K
98941 Chiropractic manipulative treatment; spinal, 3-4 regions 616 391 $16K
90834 Psychotherapy, 45 minutes with patient 575 191 $14K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 68 68 $9K
80305 892 680 $8K
H0032 Mental health service plan development by non-physician 117 92 $6K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 144 138 $5K
H2014 Skills training and development, per 15 minutes 47 12 $3K
95117 290 82 $2K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 30 29 $2K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 18 14 $2K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 30 30 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 104 95 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 13 13 $600.34
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 29 26 $226.40